If you or a loved one took Zantac (ranitidine) and later developed health complications, particularly cancer, you may be ...

How do you explain one Zantac manufacturer kiboshing a favorable trend of defense verdicts and decisions – with a massive ...

The Shocking Truth" How did Zantac, once the world's most popular drug for acid reflux and heartburn, turn into a toxic ...

British pharmaceutical company GSK on Wednesday said it swung into a net loss in the third quarter after settling lawsuits in the United States surrounding its Zantac heartburn drug.

Numerous drugs have been recalled in recent years over nitrosamine impurities, including metformin, ranitidine (Zantac), and ...

Heritage Pharmaceuticals and Apotex will pay $49.1 million in a settlement with Pennsylvania, New Jersey and other states.

UK pharmaceutical giant GSK says it will pay as much as $2.2bn (£1.68bn) to settle thousands of cases in US courts over claims that a discontinued version of its heartburn drug Zantac caused cancer.

GSK did not admit wrongdoing as part of the deal, saying in a statement that there was "no consistent or reliable evidence" that ranitidine, the drug's active ingredient, increased the risk of cancer.

Plaintiffs had argued that the company knew that Zantac’s active ingredient, ranitidine, turned into the potential carcinogen NDMA under certain conditions. The US Food and Drug Administration ...

These cases account for 93% of the Zantac (ranitidine) lawsuits currently pending against the company. Under these agreements, GSK will pay up to $2.2 billion to resolve the claims, contingent ...

such as ranitidine (Zantac), and lastly, proton pump inhibitors (PPIs) that block acid production for long enough to enable the food pipe to heal. Prescription-strength H-2 receptor blockers and PPIs ...

UK pharmaceutical giant GlaxoSmithKline (GSK) has announced a five year collaboration with Cambridge University despite claims that a discontinued version of its heartburn drug causes cancer. GSK is ...